| P50 | author | Abdollatif Moini | Q57337339 |
| P2093 | author name string | Ghasem Azimi | |
| | Abdolhay Farivar | |
| P2860 | cites work | Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. | Q54567201 |
| | Statins as a newly recognized type of immunomodulator | Q73252634 |
| | Development of the asthma control test: a survey for assessing asthma control | Q75233242 |
| | Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators | Q78017116 |
| | Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma | Q79400246 |
| | Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia | Q28176000 |
| | Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study | Q28186001 |
| | Statin therapy and autoimmune disease: from protein prenylation to immunomodulation | Q28236647 |
| | Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 |
| | Current perspectives on statins | Q33818381 |
| | New targets for modifying mast cell activation in asthma | Q36437221 |
| | T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives | Q36757665 |
| | Emerging indications for statins: a pluripotent family of agents with several potential applications | Q37066246 |
| | Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond | Q37423130 |
| | Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line | Q39826210 |
| | Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma | Q40289306 |
| | Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering | Q43516483 |
| | Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. | Q43833268 |
| | Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development | Q44620895 |
| | A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma | Q44772777 |
| | Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung | Q46331220 |
| | Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice | Q46333817 |
| | Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma | Q46403703 |
| | Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats | Q46768110 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 290-294 | |
| P577 | publication date | 2012-05-21 | |
| P1433 | published in | Allergy, Asthma & Immunology Research | Q13429052 |
| P1476 | title | Evaluation of atorvastatin for the treatment of patients with asthma: a double-blind randomized clinical trial | |
| P478 | volume | 4 | |